Search
for

    Research 10 of 582

    1. Association of JAK 1 and JAK 2 gene polymorphism with alopecia areata risk: a case–control genetic study Egyptian Journal of Basic and Applied Sciences · 2025
    2. Janus Kinase inhibitors in dermatology: a review Portuguese Journal of Dermatology and Venereology · 2023 · 1 citations
    3. Alopecia Areata: Understanding the Pathophysiology and Advancements in Treatment Modalities Cureus · 2025
    4. 54022 Pooled Safety Assessments from the Multinational Phase 3 THRIVE-AA1 and THRIVE-AA2 Trials of Deuruxolitinib in Adult Patients with Moderate to Severe Alopecia Areata Journal of the American Academy of Dermatology · 2024 · 2 citations
    5. 42736 Safety Assessments in the Multinational Phase 3 THRIVE-AA1 Trial with CTP-543 (Deuruxolitinib) in Adult Patients with Moderate to Severe Alopecia Areata Journal of the American Academy of Dermatology · 2023
    6. Personalized Medicine in the Field of Inflammatory Skin Disorders Journal of Personalized Medicine · 2022 · 2 citations
    7. Epigallocatechin-3 Gallate Inhibits STAT-1/JAK2/IRF-1/HLA-DR/HLA-B and Reduces CD8 MKG2D Lymphocytes of Alopecia Areata Patients 2018 · 15 citations
    8. 695 Selectively targeting JAK1 or JAK3 pathway is sufficient to reverse alopecia areata 2019
    9. An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis Journal of Investigative Dermatology · 2018 · 130 citations
    10. Efficacy and Potential Mechanisms of Naringin in Atopic Dermatitis International Journal of Molecular Sciences · 2024 · 4 citations
    All research results →

    Learn

    — no results

    Try a deeper search in learn →

    Community

    — no results

    Try a deeper search in community →